The discovery of new antiparasitic compounds against Trypanosoma cruzi, the etiological agent of Chagas disease, is necessary. Novel aryloxy/aryl thiosemicarbazone-based conformationally constrained analogs of thiosemicarbazones (1) and (2) were developed as potential inhibitors of the T. cruzi protease cruzain, using a rigidification strategy of the iminic bond of (1) and (2). A structureeactivity relationship analysis was performed in substituents attached in both aryl and aryloxy rings. This study indicated that apolar substituents or halogen atom substitution at the aryl position improved cruzain inhibition and antiparasitic activity in comparison to unsubstituted thiosemicarbazone. Two of these compounds displayed potent inhibitory antiparasitic activity by inhibiting cruzain and consequently were able to reduce the parasite burden in infected cells and cause parasite cell death through necrosis. In conclusion, we demonstrated that conformational restriction is a valuable strategy in the development of antiparasitic thiosemicarbazones.
Introduction
Chagas disease, caused by Trypanosoma cruzi, represents a serious and alarming health problem [1] . It affects approximately 5e10% of the population of Latin America, but even after more than 100 years since its discovery, the specific treatment of T. cruzi remains uncertain [2, 3] . Benznidazole, the drug of choice for the treatment of Chagas disease, is able to eliminate the parasite during the acute phase; however, it is poorly effective during the chronic phase, even after long-term administration, and it causes a high dropout rate during treatment due to side effects [4, 5] . Human vaccination against T. cruzi infection is not available; thus, other therapies aiming to control infection or reduce clinical symptoms are being investigated [6e8].
Knowledge of molecular targets related to various parasite processes has significantly contributed to this investigation. Key enzymes, such as cysteine proteases, are among the preferred targets for the development of new drugs. The structural and functional biochemistry of cruzain, however, is by far the most studied of the proteases in T. cruzi infections [9] . Cruzain belongs to the family of cysteine proteases (papain-like enzymes known as clan CA) and is closely related to cathepsins L and S, which are also associated with other pathologies in humans [10] . This enzyme is involved in the invasion, differentiation and proliferation of parasites in host cells [11] , and it is a useful molecular target for the rational design of anti-trypanosomal agents [12] .
Regarding the identification of cruzain inhibitors, most of the efforts have been conducted through the investigation of peptides and peptide-like compounds, such as ureas [10, 13] , hydrazones [14e17], triazoles [18, 19] and thiosemicarbazones [20e22] . Thiosemicarbazones were originally developed as potential inhibitors of cathepsin-L, one of the principal proteases involved in cancer cells [20] . However, based on the homology and similar biochemical properties between cathepsin-L and cruzain, thiosemicarbazones were investigated as a potential class of cruzain inhibitors. Later on, aryl thiosemicarbazones were found to be a class of anti-T. cruzi compounds that inhibit cruzain activity [21, 22] .
The general binding mode for aryl thiosemicarbazones with cruzain involves covalent binding of a thioamide group to a Cys25 amino acid, as well as the location of the aryl group within a deep hydrophobic pocket [22, 23] . Based on this model, a number of molecular modifications have been investigated, including bisthiosemicarbazones, heterocyclic-derived thiosemicarbazones, thiosemicarbazones containing bioreductive groups and metallic complexes [24e29] .
Recently, our group evaluated the anti-T. cruzi activity of a series of aryl thiosemicarbazones obtained by a homologation strategy. This led to the identification of new potent anti-T. cruzi agents, such as compounds (1) and (2) (Fig. 1) , which significantly inhibited the proliferation of epimastigotes (IC 50 ¼ 71.5 and 2.2 mM, respectively) and demonstrated toxicity to trypomastigotes (CC 50 ¼ 1.4 and 2.2 mM, respectively) but was not cytotoxic against spleen cells. In addition, these compounds induced T. cruzi cell death by an apoptotic process; however, they did not exhibit inhibitory activity for cruzain [30] .
In parallel to thiosemicarbazones, our group observed that thiazolidinone 18 inhibits cruzain activity but not its homologous proteins in mammalian cells (cathepsin L) [31] . However, it was several times less potent than KB2, a high-efficient cruzain inhibitor [19] . A comparison of cruzain docking between thiazolidinone 18 and KB2 has revealed that the major difference is that KB2 assumes a T-shaped conformation. Therefore, thiazolidinones presenting a T-shape conformation displayed enhanced activity than thiazolidinone (18) family. Thus, our findings were suggestive that cruzain inhibitors displaying a conformation resembling a T-shape presented in KB2 compound warrant activity (Fig. 2) .
Based on this, we sought that disrupting planarity and symmetry in aryl thiosemicarbazones (1) and (2) would lead to T-shape conformational compounds and potentially increase cruzain and antiparasitic activity. Among the chemical modifications to achieve this [32e34], we consider attaching an aryl group in the imine group which could change dihedral angles and twist the position of aryl rings, producing new conformationally constrained compounds ( Fig. 3 ).
New aryl thiosemicarbazones (8ael, 9aet) were synthesized and evaluated as anti-T. cruzi agents as well as cruzain inhibitors. First, compound 8a was prepared, which contains a phenyl ring without a substituent attached to the iminic carbon, for the purpose of comparison with substituted derivatives 8beh. Thereafter, substituents attached to the phenyl ring were examined, such as alkyl, alkoxy, halogen atoms and phenyl rings, generating biphenyl and naphthyl groups. In addition, we investigated a wide range of substituents bonded to the phenoxyl ring (9aet) to assess its functions in terms of electronic and steric contributions to anti-T. cruzi activity. We prepared 4-substituted phenyl derivatives, followed by the preparation of derivatives with one substituent in meta-or ortho-positions in the phenyl ring. Derivatives containing two substituents attached to the phenyl ring were synthesized, as well as the replacement of a phenyl by a naphthyl ring. Finally, aryl thiosemicarbazones were synthesized containing methyl or phenyl groups in N4 (8iel). Evaluation of the anti-T. cruzi and cruzain activity for these compounds (8ael, 9aet) led to the identification of important structureeactivity relationships.
Results and discussion

Synthesis
Obtaining aryl thiosemicarbazones (8ael, 9aet), as shown in Scheme 1, was performed in two steps from different phenols and halo-substituted acetophenones, both purchased commercially. Initially, various 1-phenoxy-2-acetophenones (5aeh; 6aet) were obtained from the O-alkylation of various phenols (3aet) with 2halo-acetophenones (4aeh) in a basic medium and temperature environment, similar to a protocol previously described [29] . After 3e4 h of reaction, 1-phenoxy-2-acetophenones compounds were obtained with yields varying from 77 to 95%. These intermediate compounds (5aeh; 6aet) were then reacted with some thiosemicarbazides (7aec) and catalytic HCl in an ultrasound bath at room temperature [35] . After 2.5e3 h, thiosemicarbazones (8ael, 9aet) precipitated in the reaction mixture and were collected by simple filtration. All thiosemicarbazones were recrystallized and obtained at an acceptable purity (>95%) in yields ranging from 69 to 90%. The structures were determined by 1 H and 13 C NMR, DEPT and IR.
In the 1 H NMR spectra of most compounds, it was possible to observe the presence of signals correspondent to the existence of isomers or rotamers. However, two signals for the methylene hydrogens had a chemical shift difference of approximately 0.3 ppm; in the case of rotamers, generally, two signals almost overlapped. These observations were thus suggestive of the formation of a mixture of stereoisomers (Z) and (E). Next, we aimed to define the configuration of the major isomer by crystallographic analysis. A single crystal suitable for X-ray analysis was collected from thiosemicarbazones 8e and 9h. As shown in the ORTEP-3 representation of thiosemicarbazones 8e and 9h ( Fig. 4) , the N2 and sulfur atoms are on the same side, characterizing a Z configuration for the C1]N2 bond. These compounds showed 1 H NMR chemical shifts similar to thiosemicarbazones (8ael, 9aet); therefore, it is fair to suggest that the major isomer for these thiosemicarbazones has a Z configuration about this bond. . Difference of molecular planarity between a thiosemicarbazone previously investigated (compound 9a [30] , left) and one proposed here (compound 9h, right). ORTEP-3 diagram of the compounds 9h and 9a. Displacement ellipsoids are drawn at 50% probability level. Scheme 1. Synthesis of aryl thiosemicarbazones (8ael, 9aet). Reagents and conditions: (a) K 2 CO 3 , KI, acetone, r.t., 3e4 h, yields from 77 to 95%. (b) HCl, EtOH, ultrasound bath for 2,5-3 h, yields from 69 to 90%. Ph ¼ Phenyl, Ar ¼ Aromatic ring. In contrast, in previous works developed by our group [30, 31] aryl-thiosemicarbazones were obtained that exhibited E configuration for this bond. The main structural feature that differentiates the thiosemicarbazones (8ael, 9aet) from those previously obtained [30, 31] is the presence of a phenyl group at C1. It appears that this reversal in the configuration around that bond is related to the presence of this group (Fig. 5 ).
The ratio of the stereoisomers Z/E was estimated by considering the relative intensity of the signals of the methylene protons in 1 H NMR spectra and varied according to the compound (Supplementary material). In the spectrum of compound 9c, for example, only one signal was detected, suggesting that it was obtained in the form of a single stereoisomer (Z) or that the ratio of the minor isomer (E) was so small that was not detected during analysis. In relation to the compounds 8i, 8l, 9a, 9n and 9p, the relative proportion of stereoisomers (Z:E) was: 8i (89.2:10.8), 8l (91.5:8.5), 9a (93.5:6:5), 9n (96.5:3:5), 9p (95.2:4.8), respectively.
Antiparasitic activity against extracellular forms and cytotoxicity against host cells
First, compounds 8ael and 9aet were evaluated against epimastigotes and trypomastigotes of T. cruzi. The antiparasitic activity was determined by counting the parasite number in a Neubauer chamber and calculating the concentration of the test compound resulting in 50% inhibition (IC 50 , epimastigotes) or 50% cytotoxicity (CC 50 , trypomastigotes). Cytotoxicity in host cells was determined in mouse splenocytes, measured by the incorporation of [ 3 H]thymidine, and results were expressed as the highest non-cytotoxic concentration (HNC). Benznidazole and nifurtimox were used as reference antiparasitic drugs and exhibited CC 50 values of 6.2 and 2.7 mM against trypomastigotes, respectively. As a standard, compounds with CC 50 values 6.2 mM against trypomastigotes were considered potent anti-T. cruzi compounds. The results are reported in Table 1 .
We first analyzed the antiparasitic activity against the trypomastigote form. In analyzing the activity of aryl thiosemicarbazones 8aeh, in which the structural variations were made in the para-position of the phenyl ring from the 2haloacetophenone (Ar′), it was observed that, in general, substitutions in the phenyl ring did not favor trypanocidal activity. The compound 8a (CC 50 ¼ 2.4 mM), which has no substitution in the phenyl ring, was one of the most potent compounds in the (8aeh) series, showing higher activity than reference drugs BDZ and NFX (CC 50 ¼ 6.2 and 2.7 mM, respectively).
Comparing the activity of the substituted arylthiosemicarbazones (8beh) with BDZ, all compounds exhibited a greater toxicity against trypomastigotes than this reference drug, with the exception of the compound 8h (CC 50 ¼ 14.7 mM). The attachment of electron donors groups, such as methyl (8b, CC 50 ¼ 3.1 mM) and methoxy (8c, CC 50 ¼ 5.0 mM), to the phenyl ring at the para-position decreased the antiparasitic activity. Substitutions in the para-position of the phenyl ring by the halogen atoms -F (8d, CC 50 ¼ 3.6 mM), -Cl (8e, CC 50 ¼ 5.3 mM) and -Br (8f, CC 50 ¼ 3.9 mM) also resulted in less active compounds than the unsubstituted derivative (8a). In addition, there was no correlation between the size of the halogen atomic radius and the antiparasitic activity. On the other hand, the attachment of a second phenyl ring at the para-position led to a slight increase in activity against trypomastigotes, as can be observed for compound 8g (CC 50 ¼ 2.1 mM).
These data showed similarity to those obtained in the study by Moreira et al., in which the 4-thiazolinone containing a phenyl at position 4 of the phenyl ring derived from 2-haloacetophenones are among the two most active against the parasite [36] . Interestingly, compound 8h (CC 50 ¼ 14.7 mM), which contains a bulky and hydrophobic a-naphthyl group like the biphenyl of compound 8g, showed the lowest activity among the thiosemicarbazones 8aeh.
By evaluating the trypanocidal activity of thiosemicarbazones 8iel, it can be noted that the substitution at position N4 reduced the toxicity against this evolutionary form in most cases. For example, directly comparing the activity of compounds 8k (N4eMe, CC 50 ¼ 7.4 mM) and 8l (N4ePh, CC 50 ¼ 15.6 mM) to the unsubstituted analog (8d, CC 50 ¼ 3.6 mM), a large reduction of activity is noted after this substitution.
Regarding the toxicity against trypomastigotes of arylthiosemicarbazones 9aet, in which the structural variations occur in the phenoxy ring (Ar), they all exhibited higher or similar activity in relation to reference drug benznidazole, with the exception of compounds 9q (CC 50 ¼ 28.3 mM) and 9r (CC 50 ¼ 12.3 mM). In addition, the functionalization of the phenoxy ring was generally beneficial to the activity against trypomastigote forms, as the compound 9a (CC 50 ¼ 6.6 mM), an unsubstituted derivative, was less active than substituted compounds (except compounds 9q and 9r).
In comparison to 9a, anti-T. cruzi activity was enhanced when an alkyl group was attached to the para-position of the phenoxy ring. Thiosemicarbazone 9b (CC 50 ¼ 1.8 mM), with an ethyl group, was about three times more potent. Compounds 9c (CC 50 ¼ 2.9 mM) and 9d (CC 50 ¼ 2.2 mM), which have branched alkyl groups, also demonstrated increased antiparasitic activity, although with slightly less intensity than the linear alkyl chain analog (9b). The attachment of methoxy groups to the phenyl ring also generated more active compounds, as can be observed for thiosemicarbazones 9e (CC 50 ¼ 1.2 mM) and 9f (CC 50 ¼ 3.7 mM), substituted at the meta-and para-positions, respectively. However, the compound 3-methoxy substituted (9e) was the most potent of all of the thiosemicarbazones assessed in this study, approximately five times more active than BDZ. Binding of an acetamide group in the para-position of the phenoxy ring (9g, CC 50 ¼ 3.5 mM) increased activity compared with 9a. However, this increase was not as significant as what was observed in previous work from our group, in which the derivative containing such a substituent was among the most active [30] . We also evaluated the antiparasitic activity against trypomastigotes by thiosemicarbazones containing different halogens attached to the phenoxy ring. All derivatives containing halogens were more active than the unsubstituted thiosemicarbazone 9a, revealing the importance of this structural modification for antiparasitic activity. By comparing the activity of compounds 9p (CC 50 ¼ 2.1 mM), 8f (CC 50 ¼ 3.9 mM) and 9l (CC 50 ¼ 5.7 mM), which show the atoms -I, -Br and -Cl at position 4 of the phenoxy ring, respectively, a potential increase of antiparasitic activity was observed according to the increase of the atomic radius of bound halogen. This trend was also observed in a previous study by our group [30] . We also analyzed the effect of binding chlorine atoms in different positions of the phenoxy ring, ortho-(9j, CC 50 ¼ 6.0 mM), meta-(9k, CC 50 ¼ 1.6 mM) and para-(9l, CC 50 ¼ 5.7 mM). The metasubstitution generated the most active chlorine derivative and one of the most active compounds in this study. Moreover, di-substitutions were also evaluated in the phenoxy ring by halogen atoms, giving rise to compounds 9i (3-Cl,4-FePh), 9m (2,3-diClePh) and 9n (3,4-diClePh). These compounds were more active in relation to compound 9a, especially thiosemicarbazone 9i, one of the most trypanocidal of the series with a CC 50 ¼ 1.7 mM, higher than even the reference drug.
The anti-trypanosomal activity for compounds 9p, 8f and 9l increased with the atomic radius of their halogen atoms, suggesting the steric effect is important for activity. Based on this, we evaluated thiosemicarbazones 9q and 9r, which possess a second phenyl ring attached to the phenoxy ring in the positions 3 and 4, respectively. Compounds 9s and 9t, fitted with a naphthyl ring attached to the imine carbon in a and b positions, respectively, were also obtained. The thiosemicarbazones containing biphenyl 9q (CC 50 ¼ 28.3 mM) and 9r (CC 50 ¼ 12.3 mM) were inactive, whereas the compounds containing the naphthyl group 9s (CC 50 ¼ 3.4 mM) and 9t (CC 50 ¼ 5.0 mM) only maintained the antiparasitic activity, with the replacement in the position a most favorable. As observed, not only the steric and hydrophobic effects of the substituents in the phenoxy ring are responsible for the potentiation of trypanocidal activity.
Once the toxic activity of all compounds (8ael, 9aet) for the T. cruzi trypomastigotes had been determined, we investigated the antiproliferative effect for T. cruzi epimastigotes. BDZ, one of the reference drugs used in the experiments, exhibited an IC 50 of 48.8 mM while NFX presented an IC 50 of 5.7 mM on this parasite form. All thiosemicarbazones evaluated in this study were more active than the reference drug BDZ.
Regarding the cytotoxicity to splenocytes, most aryl thiosemicarbazones evaluated in this study (8ael, 9aet) caused higher toxicity than the reference drug benznidazole, with the exception of compound 9a, which was non-toxic at concentrations up to 137.3 mM, and compound 9c, which was non-toxic to the highest concentration tested (246.0 mM). Taking into account the selectivity, the aryl thiosemicarbazone 9c stood out among all compounds evaluated, displaying excellent trypanocidal activity for both parasite forms of T. cruzi and lower toxicity to splenocytes than the reference drugs. In addition, Lipinski et al. present four criteria that are important to study the pharmacokinetics and drug development. A molecule that agrees with three criteria, would present a good pharmacokinetic and became a drug candidate [37] . It is interesting to note that the calculated values in Table 2 show that thiosemicarbazone 9c as well as the unsubstituted derivative (9a) meet the criteria of Lipinski. On the other hand, structurallysimple thiosemicarbazones present limited aqueous solubility.
Anti-T. cruzi activity against amastigote and trypomastigote forms infecting a vertebrate cell
Due to the good activity shown against epimastigote and trypomastigote forms of T. cruzi, the compounds were also assayed in vitro against the T. cruzi amastigote form, which represents the intracellular form of the parasite. For this, we used a tissue cell culture system that allows evaluating the activity against both amastigote and trypomastigote forms simultaneously because the lengthy time of the assay (seven days) allows compounds to act on trypomastigotes released starting from four days post-infection. This method is considered the in vitro method of choice in screening drugs for activity against T. cruzi because it mimics the lifecycle of the parasite [38, 39] .
Results were expressed as the percent of inhibition of parasite growth after treatment with each compound. A cell viability test was performed to evaluate the cytotoxicity of the compounds against the murine fibroblast L-929 cell line [39, 40] . The concentrations that caused 50% inhibition of the parasite growth (IC 50 ) were evaluated for the more potent compounds (those presenting more than 70% inhibition in the initial screening at 100 mM) (Table 3) . , which has a phenyl ring at the same position, was the more active compound tested, suggesting that the presence of bulky and hydrophobic substituents, as bromine and phenyl, may be associated with improved activity. In addition, thiosemicarbazone 8h (IC 50 ¼ 4.8 mM), also containing a bulky and hydrophobic grouping (naphthyl), is among the most active of the series, suggesting the steric nature of these groups positively influences activity against these forms of the parasite.
Considering the anti-T. cruzi activity of thiosemicarbazones 9aet against these parasite forms, it is noted that substitutions in the phenoxy ring (Ar) gave less active compounds compared with the unsubstituted derivative 9a (IC 50 ¼ 5.4 mM). However, some structureeactivity relationships were identified in this series. Comparing the activity of compounds 9b, 9c and 9d (IC 50 ¼ 6.4, 12.3 and 15.2 mM, respectively), a reduction in the trypanocidal activity was observed with increased branching of the alkyl chain attached to position 4 in the phenoxy ring. A potentiation of the trypanocidal activity was observed with an increased halogen atomic radius linked to the same ring position by the order: 9h (4-F, Fig. 6 ).
Furthermore, the presence of a halogen at position 4 of the ring contributed more significantly to the activity than position 3, as is seen in the comparison of compounds 9l (4-Cl, IC 50 ¼ 11.2 mM), and 8f (4-Br, IC 50 
The cytotoxicity of the active compounds on uninfected fibroblasts was established in vitro to evaluate the selectivity of their antiparasitic effects. The selectivity index (SI) was calculated as the ratio of the CC 50 value in uninfected cells (cytotoxicity) to the IC 50 in parasite cells (Table 3) . Although most of the compounds exhibited low selectivity, thiosemicarbazones 9a, 9f and 9t showed moderate selectivity (SI > 10), suggesting that these compounds could be prototypes for new trypanocidal drugs.
Cruzain inhibition activity
To investigate a possible mechanism of action, compounds were tested against the enzyme cruzain of the T. cruzi. The inhibition of cruzain enzymatic activity by all compounds was measured using a competition based assay with the substrate Z-Phe-Arg-aminomethylcoumarin (Z-FR-AMC) [41] . All compounds were screened at 50 mM, and only compounds having an inhibition value of >70% were chosen to determine IC 50 values. However, the IC 50 values of many compounds exhibiting an inhibition percentage above this value (70%) could not be established due to their low solubility, which made it impossible to achieve cruzain inhibition high enough (>85%) for a good curve determination. Therefore, in some cases, the discussion was performed in terms of the percentage of cruzain inhibition (Table 3) .
Analyzing the potential for inhibition of thiosemicarbazones 8aeh, it was observed that the substitution of methoxy group and the halogens -F, -Cl and -Br held in position 4 of the phenyl ring Ar′ of compound 8a did not favor inhibitory activity. On the other hand, the compounds 8b (4-CH 3 ), 8g and 8h showed good inhibition percentages (70.9, 88.9 and 73.6%, respectively), and 8g showed an IC 50 of 0.6 ± 1.5 mM. A common feature of the latter two compounds is the presence of bulky and hydrophobic groups, biphenyl (8g) and naphthyl (8h), attached to C1; previous docking models demonstrated interaction with the subsite S3 enzyme [31] .
The 8iel thiosemicarbazone showed little activity against cruzain, suggesting that replacements at N4, either methyl or phenyl grouping, are not conducive to enzyme inhibition. These results confirm data obtained in the study conducted by Du et al. [20] in which it was observed that the binding of various alkyl and aryl radicals in this position generated inactive compounds.
By observing the inhibitory potential of aryl thiosemicarbazones 9aet, in which the structural variations were made in phenoxy ring Ar, it is noted that several of them (9b, 9d, 9fei, 9leo, 9t) had percentages of inhibition greater than 70%. Relative to compound 9a, substitutions at position 4 of the phenyl ring by alkyl substituents ethyl (9b) and tert-butyl (9d) had increased activity, while thiosemicarbazone 9c (4-i-propyl) was less active. The addition of methoxy substituents at positions 3 and 4 of the phenoxy ring (9e and 9f, respectively) slightly favor enzyme inhibition, so that the compound substituted at position 4 (9f) was more active. The work carried out by Du et al. [20] and Siles et al. [22] explained that the presence of halogens in the phenyl ring of some aryl thiosemicarbazones contributes to the inhibition of cruzain. In fact, thiosemicarbazones containing halogens (F, Cl, Br, and I) in the phenyl ring (8f, 9hep) generally showed good percentages of inhibition. These values generally decreased according to the size of the atomic radius of the halogen attached to the phenyl ring at position 4, as can be observed in compounds 9h (4-F) > 9l (4-Cl) > 8f (4-Br) to 84.0 (IC 50 ¼ 0.4 ± 2.1 mM), 73.6 and 11.8%, respectively. Furthermore, the phenyl ring disubstituted by these halogens increased the inhibition percentage, as demonstrated by thiosemicarbazones 9i [20] . The other thiosemicarbazone that stood out in the studies conducted by the authors and Siles et al. was that which contained a bromine atom at position 3 of the phenyl ring. Similarly, compound 9o, which contains the same substitution in the phenoxy ring, exhibited an inhibition percentage of 81.3% [20, 22] .
Considering all evaluated aryl thiosemicarbazones (8ael, 9aet), compounds 8g, 9d, 9gei, and 9meo inhibited over 80% of T. cruzi cruzain activity in the screening at 50 mM. However, the IC 50 was determined only for compounds 8g, 9hei and 9n. Moreover, Fig. 6 . Relationship of atomic radius and antiparasitic activity. thiosemicarbazones 9i and 9n are noteworthy because they present an IC 50 of 0.07 ± 1.2 and 0.008 ± 1.6 mM, respectively, comparable to the most potent cruzain inhibitors described in the literature, such as compound K11777 (IC 50 ¼ 0.004 mM) [42] .
Thiosemicarbazones 9i and 9n have not been the most active in vitro against the parasite, although the thiosemicarbazone 9i (IC 50 ¼ 1.7 mM) is among the three most active front trypomastigote form. This may be related to the fact that the in vitro test front cruzain was done directly in the isolated enzyme, avoiding the effect of the parasite biological barriers, such as permeability cell. Moreover, it is probably that our compounds act by other mechanisms of action, since some of them exhibited modest cruzain inhibition percentage and good in vitro activity against the parasite.
The fact is that the strategy of disruption of the planarity mentioned above (Fig. 3 ) [30] , providing a T-shaped conformation by inserting aryl groups at C1 appears to have been effective. Directly comparing the percentage of cruzain inhibition by compound (1) with compound 9g, it is observed that compound (1) did not inhibit the enzyme even at a concentration of 100 mM. Thiosemicarbazone 9g, containing a T-shaped conformation, inhibited the enzyme with a percentage of approximately 80.7% using a concentration of 50 mM, half of the former. In addition to compounds (1) and (2), none of the thiosemicarbazones evaluated in a previous study [30] demonstrated activity against cruzain.
Flow cytometry analysis
After confirming that these thiosemicarbazones were able to kill T. cruzi parasites, our next step was to understand how they lead to cell death. Therefore, we treated Y strain trypomastigotes with 0.5 mM (average IC 50 values) or 5.0 (10Â IC 50 values) of each thiosemicarbazone and incubated them for 24 h. Cells were then stained with propidium iodide (PI) and examined by flow cytometry. As shown in Table 4 , the positive control (Triton X) led to 67% of cells positively stained for PI. When compared with untreated cells, most of the parasite cells treated with thiosemicarbazones positively stained for PI. Thiosemicarbazone 9c was the most potent among them, exhibiting concentration-dependent activity ( Fig. 7) . Moreover, compound 9c at 5.0 mM was more efficient in inducing parasite cell death than benznidazole at its optimal concentration (25 mM). Therefore, we suggest that thiosemicarbazonebased treatment causes parasite cell death through necrosis.
Conclusions
Using a simple and fast method, 32 aryl thiosemicarbazones were synthesized. The trypanocidal activity of these compounds was evaluated for three life stages of the parasite. Most of the compounds exhibited superior activity over the reference drug BDZ against epimastigote and trypomastigote forms of T. cruzi.
Compounds 9a and 9c showed broad and selective antiparasitic activity against T. cruzi. Compound 9c was most selective against the extracellular forms of the parasite and showed non-toxicity on mouse splenocytes at the highest concentration tested. Among all compounds tested, 14 inhibited cruzain at rates higher than 70%, demonstrating that changes in the molecular conformational and planarity in thiosemicarbazones increases the affinity to the cruzain binding site. Thiosemicarbazones 9i and 9n were shown to be potent inhibitors, comparable to the compound K11777, a highly potent cruzain inhibitor.
Experimental section
General
Most the chemicals were purchased from SigmaeAldrich (St. Louis, MO, USA), Merck (Berlin, Germany) or Alfa-Aesar (Ward Hill, MA, USA). Reactions in ultrasound bath were performed in a Unique EM-804 TGR instrument, with a frequency of 40 kHz and a nominal power of 180 W, and without external heating. Precoated aluminum sheets (silica gel 60 F254, Merck) were used for thinlayer chromatography (TLC) and spots were visualized under UV light. Elemental analysis was performed with a Carlo Erba instrument model E-1110. IR spectra in KBr pellets were acquired at Bruker FT-IR spectrophotometer. 1 H and 13 C NMR were recorded on a Uni-tyPlus 400 MHz and Bruker AMX-300 MHz spectrometer, using DMSO-d 6 as a solvent and trimethylsilane (TMS) as the internal standard. Splitting patterns were defined as; s, singlet; d, doublet; dd, double doublet; t, triplet; q, quartet; m, multiplet. Chemical shift values were given in ppm. DEPT was employed to confirm the carbon assignment.
Synthesis of 1-phenoxy-2-acetophenones (5aeh; 6aet). Example for 2-(4-bromophenoxy)-1-(4-methoxyphenyl)ethan-1one (5c)
In a round bottom flask with a capacity of 100 mL, were added 13.2 mmol (2.3 g) of 4-bromophenol, 35 mL of acetone, 13.2 mmol (1.8 g) of powdered K 2 CO 3 and KI in catalytic amount. The mixture was kept under magnetic stirring at room temperature. After 30 min, 8.8 mmol (2.0 g) of 2-bromo-1-(4-methoxyphenyl)ethan-1-one are added in portions. The reaction was kept under magnetic stirring at room temperature for 3.0 h. After completion of the reaction, the reaction mixture was filtered, so that the supernatant was evaporated under reduced pressure and the precipitate (K 2 CO 3 ) discarded. After evaporation, a solid was obtained, which was resuspended using diethyl ether and then filtered. The crystal obtained was transferred to a desiccator and placed under vacuum SiO 2 . The resulting product was used in the next step without further purification.
Synthesis of thiosemicarbazones (8ael, 9aet). Example for 2-(4-bromophenoxy)-1-(4-methoxyphenyl)ethan-1-one thiosemicarbazone (8c)
In a round bottom flask for 100 mL, 8.1 mmol (2.6 g) of 1phenoxy-2-acetophenone 5c were dissolved in 30 mL EtOH, following by the addition of four drops HCl. The flask was placed in an ultrasound bath (40 kHz, 180 W) and under sonication, 10.5 mmol (1.0 g) of thiosemicarbazide 7a were added in portions to the reaction. After 2.5 h, the mixture was cooled at 0 C and the precipitate was filtered in a Büchner funnel with a sintered disc filter, washed with cold water, ethanol and then dried over SiO 2 . After drying, the product was recrystallized from toluene. 10 .96 (s broad, 1H, NH). 13 10 .91 (s broad, 1H, NH). 13 11 .00 (s broad, 1H, NH). 13 
Anti-T. cruzi activity (epimastigotes)
Epimastigotes (Dm28c strain) grown in LIT media were counted in a hemocytometer and then seeded at 10 6 cells/well into a 96well plate. Compounds were dissolved in DMSO and then diluted in LIT m edium in a serial dilution (1.23, 3.70, 11.11, 33.33 and 100 mg/mL) and added to respective wells, in triplicate. The final DMSO concentration in the plate was 1%. Plate was incubated for 5 days at 26 C, aliquots of each well were collected, and the number of viable parasites were counted in a Neubauer chamber and compared to untreated parasite culture. Inhibitory concentration for 50% (IC 50 ) was calculated using nonlinear regression on Prism 4.0 GraphPad software. Benznidazole and nifurtimox were used as the reference drugs.
Anti-T. cruzi activity (trypomastigotes)
Metacyclic trypomastigotes were collected from the supernatant of infected LLC-MK2 cells and then seeded at 4 Â 10 5 cells/well in RPMI-1640 medium. All compounds were dissolved in DMSO and then diluted in RPMI-1640 medium in a serial dilution (1.23, 3.70, 11.11, 33.33 and 100 mg/mL) and added to respective wells, in triplicate. The final DMSO concentration was 1%. Plate was incubated for 24 h at 37 C and 5% of CO 2 . Aliquots of each well were collected, and the number of viable parasites was counted in a Neubauer chamber. The percentage of inhibition was calculated in relation to untreated cultures. Cytotoxic concentration for 50% (CC 50 ) was determined using nonlinear regression with Prism 4.0 GraphPad software. Benznidazole and nifurtimox were used as the reference drugs.
Anti-T. cruzi activity (amastigotes/trypomastigotes)
The in vitro anti-trypanosomal activity in amastigote and trypomastigote forms of T. cruzi was evaluated by colorimetric betagalactosidase assay developed by Buckner et al. (1996) [50] and modified by Romanha et al. (2010) [39] . T. cruzi (Tulahuen strain) expressing the Escherichia coli beta-galactosidase gene were grown on monolayer of mouse L-929 fibroblasts. Cultures assayed for beta-galactosidase activity were grown in RPMI 1640 medium without phenol red plus 10% fetal bovine serum and glutamine. Ninety-six-well tissue culture micro plates were seeded with L-929 fibroblasts at 4.0 Â 10 3 per well in 80 mL and incubated overnight at 37 C, 5% CO 2 . Beta-galactosidase-expressing trypomastigotes were then added at 4.0 Â 10 4 per well in 20 mL. After 2 h, the medium with trypomastigotes that have not penetrated in the cells was discarded and replaced by 200 mL of fresh medium. After 48 h, the medium was discarded again and replaced by 180 mL of fresh medium and 20 mL of test compounds. Each compound was tested in quadruplicate. After 7 days culture development, chlorophenol red beta-D-galactopyranoside at 100 mM and Nonidet P-40 at 0.1% were added to the plates and incubated overnight, at 37 C. The absorbance was measured at 570 nm in an automated microplate reader.
Benznidazole at its IC 50 (1 mg/mL ¼ 3.81 mM) was used as positive control. The results are expressed as percentage of parasite growth inhibition. Two independent experiments were performed.
Cytotoxicity in mouse L-929 fibroblasts
The active compounds were tested in vitro for determination of cytotoxic over L-929 cells using the alamarBlue ® dye. Were used the same cell number, time of the cell development and time of compound exposure used for the beta-galactosidase assay. The cells were exposed to compounds at crescents concentrations starting at IC 50 value of the T. cruzi. The compounds were tested in quadruplicate. After 96 h of exposure, alamarBlue ® was added and the absorbance at 570 and 600 nm was measured 6 h later. The cell viability was expressed as the percentage of difference in the reduction between treated and untreated cells [39] . CC 50 values were calculated by linear interpolation and the selectivity index (SI) was determined based on the ratio between CC 50 and IC 50 values.
Inhibition of catalytic activity of cruzain
The cruzain activity was measured by monitoring the cleavage of the fluorescent substrate Z-Phe-Arg-aminomethylcoumarin (Z-FR-AMC), in a Synergy 2 (Biotek) fluorimeter, of the Centre for Flow Cytometry Fluorimetry at the Department of Biochemistry and Immunology from the Federal University of Minas Gerais (UFMG), Brazil. All assays were performed in a buffer solution of 0.1 M sodium acetate pH 5.5 in the presence of 1 mM betamercaptoethanol, 0.01% Triton X-100, 0.5 nM cruzain and 2.5 mM of substrate (K m ¼ 1 mM). Initially the compounds were pre-incubated in a solution containing the enzyme. After 10 min of incubation the substrate was added. The enzymatic activity was calculated based on comparison with DMSO control, from initial rates of reaction. The screen with 50 mM of inhibitor was performed at least twice, each in triplicate, and was monitored for 5 min. IC 50 determinations were performed at least twice for each compound, and each curve was constructed based on at least seven compound concentrations, each in triplicate, with the software GraphPad Prism 5.
PI staining
Y strain trypomastigotes (4 Â 10 5 ) in RPMI-1640 medium supplemented with 10% FBS were treated with benznidazole (25 mM) or thiosemicarbazones and incubated for 24 h at 37 C in 5% CO 2 .
Triton X-100 (SigmaeAldrich, 10 mL) was used as positive control. Parasites were labeled with 5 mL PI from the BD apoptosis detection kit (BD Pharmingen, New Jersey, USA) according to the manufacturer instructions. Acquisition of at least 10,000 events was performed using a FACSCalibur flow cytometer (BD Biosciences, San Jose, CA, USA), and data were analyzed using CellQuest software (BD Biosciences). Two independent experiments were performed.
